Jefferies’ 10% Bet on Commerzbank Adds Pressure as Berlin Lays Out Its Terms
The battle for Commerzbank has gained a powerful new player. Jefferies Financial Group disclosed on July 20 that…
Novo Nordisk’s Buyback Blitz Masks Building Pressure Ahead of 2027 Price Cuts
The Danish pharmaceutical heavyweight is buying back shares at a record pace, yet the same weekly disclosures that…
Novo Nordisk’s ADA Data: One Success, One Setback, and a Stock Under Pressure
Novo Nordisk shares drop 16% YTD after CagriSema fails non-inferiority vs Lilly’s Zepbound; Zenagamtide Phase 2 shows strong…
Brussels redoubles pressure on Spain over the regulation used against the Sabadell takeover bid
You might be interested in More than 509,000 travelers stop taking the high speed between Madrid and Barcelona…
Novo Nordisk Taps European Approvals and a Gulf Hub as US Price Pressure Persists
Novo Nordisk gains EU endorsements for oral and high-dose Wegovy, plans MASH data, and builds a UAE logistics…
Novo Nordisk Balances Canadian Price Pressure With Sickle Cell Advance and Oral Pill Triumph
Novo Nordisk rebounds 31% on obesity data, but Canada generic semaglutide threatens pricing. Wegovy oral pill sales surge…
Novo Nordisk’s Oral Wegovy Smashes Expectations, but Margin Pressure and Rival Threats Cloud the O
Oral Wegovy nearly doubles Q1 sales, Citi boosts long-term forecast to 50B kr, but competition and pricing headwinds…
Novo Nordisk Faces a Fork in the Road as Pipeline Progress Meets Profit Pressure
Novo Nordisk stock trades 50% below peak amid GLP-1 competition from Eli Lilly’s oral pill, regulatory wins, and…
Lech Poznań – Legia Warszawa: 3-point gap, title pressure and a night that could reshape the race
Lech Poznań – Legia Warszawa is being framed as the weekend’s biggest Ekstraklasa fixture for good reason: it…
Novo Nordisk Shares Face Pressure Amid Pricing Concerns and Analyst Caution
Novo Nordisk shares fall as US pricing deal slashes Wegovy/Ozempic revenue. New board and pipeline assets offer some…
Novo Nordisk Faces Investor Scrutiny Amid U.S. Pricing Pressure
Novo, Nordisk
26.03.2026 – 06:56:58 | boerse-global.de
Novo Nordisk faces revenue pressure from U.S.…
Orsted Shares Face Technical Pressure Amid Board Reshuffle
Orsted shares fell ~6%, breaking key technical levels. The firm holds its 2025 EBITDA guidance. Investors await AGM…